Medical Device News Magazine

Advanced Sterilization Products Receives 510(k) Clearance for ASP AEROFLEX ™ Automatic Endoscope Reprocessor

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Advanced Sterilization Products announced today they received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ASP AEROFLEX ™ Automatic Endoscope Reprocessor (AER). The high-level disinfection system, which is designed to be used to clean and disinfect flexible endoscopes from a wide range of manufacturers, offers the fastest complete cycle time – just 22 minutes – of any AER currently sold in the United States.*

Flexible endoscopes are costly, complex and fragile instruments commonly used in minimally invasive procedures and are required to be high-level disinfected between every patient use. To effectively disinfect a flexible endoscope, it is essential that the active ingredient in the high-level disinfectant (HLD) be at or above the level required to kill microorganisms. According to professional society standards and HLD instructions for use, this critical measurement, known as the minimum recommended concentration (MRC), should be taken every time an endoscope is reprocessed.

Advanced Sterilization Products reports the current method requires dipping a test strip into the HLD and subjectively assessing the color change of the test strip against a visual scale. Given the manual nature of this process, testing may be missed or done incorrectly. AEROFLEX is the only AER with AUTOSURE™ MRC Monitor, an integrated system to automatically test HLD MRC levels every cycle, eliminating the need for manual test strips.

It is estimated that 32 million gastrointestinal (GI) endoscopy procedures using a flexible endoscope are performed each year in the United States. To keep pace with procedure demands, endoscopy managers are looking for ways to decrease the time and effort required to confidently reprocess endoscopes.

AEROFLEX with AUTOSURE is designed to ensure MRC testing compliance and increase productivity in the endoscopy suite,” said Amy Smith, Vice President of Advanced Sterilization Products. “Additionally, this is an integrated system with intuitive functionality that’s intended to be quick and easy to learn and operate. ASP remains committed to continually improving delicate instrument reprocessing with innovations that make a real difference in every day practice.”

AEROFLEX with AUTOSURE will be equipped with a touchscreen user interface and an electronic records management system designed to improve efficiency, accuracy and compliance with record keeping requirements compared to manual systems.

Note: *In countries where distributed. Includes wash, high-level disinfection, rinses, MRC testing and alcohol flush. For all qualified endoscopes except duodenoscopes which require additional time. Assuming nominal conditions for water pressure, flow rate and temperature.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”